Breaking News Instant updates and real-time market news.

TRVN

Trevena

$0.94

(0.00%)

07:23
10/12/18
10/12
07:23
10/12/18
07:23

Trevena downgraded to Hold from Buy at Needham

  • 02

    Nov

TRVN Trevena
$0.94

(0.00%)

10/13/17
OPCO
10/13/17
NO CHANGE
Target $5
OPCO
Outperform
Trevena selloff yesterday likely overdone, says Oppenheimer
Oppenheimer analyst Derek Archila views Trevena's restructuring plan as a "smart move" with the company needing to conserve cash for an Olinvo approval/launch in the second half of 2018. The analyst continues to believe Olinvo for post-surgical pain will find its "niche" as a treatment for patients at high risk of opioid related adverse events. He views yesterday's 15% pullback as likely overdone and keeps an Outperform rating on Trevena. The analyst, though, cut his price target for the shares to $5 from $8.
10/16/17
LEHM
10/16/17
DOWNGRADE
Target $2.5
LEHM
Equal Weight
Trevena downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Douglas Tsao downgraded Trevena to Equal Weight and cut his price target for the shares to $2.50 from $15. The analyst says the downgrade reflects uncertainty in the commercial outlook for Olinvo. He sees a financing overhang and limited catalysts for the shares.
03/08/18
HCWC
03/08/18
NO CHANGE
Target $7
HCWC
Buy
Trevena price target raised to $7 from $5 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce raised his price target for Trevena to $7 amid the "countdown to critical near-term value inflection points." The analyst notes the FDA action date for Olinvo in moderate to severe acute pain is November 2, 2018. He reaffirms a Buy rating on the shares.
10/10/18
JEFF
10/10/18
DOWNGRADE
Target $1
JEFF
Hold
Trevena downgraded to Hold from Buy at Jefferies
Jefferies analyst Biren Amin downgraded Trevena to Hold and cut his price target for the shares to $1 from $10. The FDA has an unfavorable view on both efficacy and safety profile of the company's oliceridine versus morphine, Amin tells investors in a research following yesterday's briefing documents. More critically, the documents make clear that Trevena failed to heed critical FDA advice in its Phase III trial design, the analyst adds. He sees no clear path forward for oliceridine.

TODAY'S FREE FLY STORIES

EGO

Eldorado Gold

$0.92

0.0007 (0.08%)

09:25
10/18/18
10/18
09:25
10/18/18
09:25
Initiation
Eldorado Gold initiated  »

Eldorado Gold initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

BTI

British American Tobacco

$43.09

1.18 (2.82%)

09:24
10/18/18
10/18
09:24
10/18/18
09:24
Downgrade
British American Tobacco rating change  »

British American Tobacco…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRFHF

Fairfax Financial

$0.00

(0.00%)

09:23
10/18/18
10/18
09:23
10/18/18
09:23
Upgrade
Fairfax Financial rating change  »

Fairfax Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMS

Fresenius Medical

$41.49

-8.37 (-16.79%)

09:22
10/18/18
10/18
09:22
10/18/18
09:22
Downgrade
Fresenius Medical rating change  »

Fresenius Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DCPH

Deciphera

$28.70

-0.01 (-0.03%)

09:21
10/18/18
10/18
09:21
10/18/18
09:21
Conference/Events
Deciphera has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 24

    Oct

  • 27

    Nov

BMTC

Bryn Mawr Bank

$44.65

0.15 (0.34%)

09:18
10/18/18
10/18
09:18
10/18/18
09:18
Earnings
Bryn Mawr Bank reports Q3 adj. EPS 84c, consensus 82c »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
10/18/18
10/18
09:18
10/18/18
09:18
Options
Overnight activity included 195 trades in SPX and 9 trades in VIX »

195 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRB

American River

$15.20

(0.00%)

09:17
10/18/18
10/18
09:17
10/18/18
09:17
Earnings
American River reports Q3 EPS 20c, consensus 22c »

During the third quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

ECYT

Endocyte

$15.55

-0.4 (-2.51%)

, NVS

Novartis

$85.34

-0.41 (-0.48%)

09:16
10/18/18
10/18
09:16
10/18/18
09:16
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Endocyte (ECYT),…

ECYT

Endocyte

$15.55

-0.4 (-2.51%)

NVS

Novartis

$85.34

-0.41 (-0.48%)

ACOR

Acorda Therapeutics

$19.19

-0.7 (-3.52%)

PM

Philip Morris

$84.62

1.12 (1.34%)

AA

Alcoa

$36.71

0.51 (1.41%)

ERIC

Ericsson

$8.74

0.11 (1.27%)

SAP

SAP

$115.86

-1.56 (-1.33%)

TXT

Textron

$64.72

-2.01 (-3.01%)

SEE

Sealed Air

$35.28

-0.12 (-0.34%)

URI

United Rentals

$139.04

-2.15 (-1.52%)

ACRS

Aclaris Therapeutics

$12.14

-0.29 (-2.33%)

ADI

Analog Devices

$85.27

-0.48 (-0.56%)

MXIM

Maxim Integrated

$52.84

-0.13 (-0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 07

    Nov

  • 27

    Nov

  • 05

    Jan

  • 18

    Oct

CSLT

Castlight Health

$2.62

0.04 (1.55%)

09:15
10/18/18
10/18
09:15
10/18/18
09:15
Recommendations
Castlight Health analyst commentary  »

William Blair sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 14

    Nov

DTRM

Determine

$0.58

-0.01 (-1.69%)

09:14
10/18/18
10/18
09:14
10/18/18
09:14
Hot Stocks
GTT choses Determine's procure-to-pay solution »

Determine announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PACW

PacWest Bancorp

$44.20

-0.14 (-0.32%)

09:13
10/18/18
10/18
09:13
10/18/18
09:13
Recommendations
PacWest Bancorp analyst commentary  »

PacWest Bancorp price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

PM

Philip Morris

$84.62

1.12 (1.34%)

09:13
10/18/18
10/18
09:13
10/18/18
09:13
Hot Stocks
Philip Morris says KFDA comments impacting those new to IQOS »

Says KFDA comments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

ATOM

Atomera

$4.65

(0.00%)

09:12
10/18/18
10/18
09:12
10/18/18
09:12
Initiation
Atomera initiated  »

Atomera initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

CGIX

Cancer Genetics

$0.82

0.01 (1.23%)

09:10
10/18/18
10/18
09:10
10/18/18
09:10
Hot Stocks
Cancer Genetics enters strategic partnership with Genecast Biotechnology »

Cancer Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BL

BlackLine

$45.55

-0.01 (-0.02%)

, TRUE

TrueCar

$12.14

-0.1 (-0.82%)

09:10
10/18/18
10/18
09:10
10/18/18
09:10
Hot Stocks
BlackLine names Susan Otto as chief people officer »

BlackLine (BL) announced…

BL

BlackLine

$45.55

-0.01 (-0.02%)

TRUE

TrueCar

$12.14

-0.1 (-0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 13

    Nov

CCB

Coastal Financial

$16.25

0.05 (0.31%)

09:10
10/18/18
10/18
09:10
10/18/18
09:10
Hot Stocks
Coastal Financial hires Erika Heer as CHRO »

Coastal Financial hired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:10
10/18/18
10/18
09:10
10/18/18
09:10
General news
Fed dove Bullard said monetary policy is about right »

Fed dove Bullard said…

09:10
10/18/18
10/18
09:10
10/18/18
09:10
General news
The Philly Fed slipped to 22.2 »

The Philly Fed slipped to…

SPN

Superior Energy

$9.62

-0.25 (-2.53%)

09:09
10/18/18
10/18
09:09
10/18/18
09:09
Downgrade
Superior Energy rating change  »

Superior Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

PM

Philip Morris

$84.62

1.12 (1.34%)

09:09
10/18/18
10/18
09:09
10/18/18
09:09
Hot Stocks
Philip Morris sees Q4 net revenue down about 5%, reflecting difficult comps »

Says September YTD net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

IBM

IBM

$134.05

-10.97 (-7.56%)

, LNVGY

Lenovo

$0.00

(0.00%)

09:09
10/18/18
10/18
09:09
10/18/18
09:09
Hot Stocks
IBM signs $240M agreement with Lenovo for AI call center technology »

IBM (IBM) will supply…

IBM

IBM

$134.05

-10.97 (-7.56%)

LNVGY

Lenovo

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 13

    Nov

  • 03

    Mar

TMO

Thermo Fisher

$234.64

-0.59 (-0.25%)

09:09
10/18/18
10/18
09:09
10/18/18
09:09
Downgrade
Thermo Fisher rating change  »

Thermo Fisher downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 24

    Oct

HAL

Halliburton

$39.56

-0.52 (-1.30%)

09:09
10/18/18
10/18
09:09
10/18/18
09:09
Downgrade
Halliburton rating change  »

Halliburton downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

STIM

Neuronetics

$22.50

-1.63 (-6.76%)

09:07
10/18/18
10/18
09:07
10/18/18
09:07
Recommendations
Neuronetics analyst commentary  »

Neuronetics fundamentals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.